CLINICAL_TRIALS
trial_result
· 2019-12-16
Clinical Trial Update: The Bihormonal iLet Bionic Pancreas Feasibility Study [Phase 2, Phase 3]
Summary
Feasibility study results for the bihormonal iLet bionic pancreas in Type 1 Diabetes Mellitus completed phase 2/3.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Type 1 Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-12-16